Cvs Health (CVS) Cost of Revenue (2009 - 2026)

Cvs Health's Cost of Revenue history runs 18 years deep, the most recent figure standing at $10.9 billion for Q1 2026.

• Quarterly Cost of Revenue fell 78.57% year-over-year to $10.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158.4 billion (down 48.26% YoY) and the FY2025 annual result came in at $221.2 billion, up 7.21% from the prior year.
• Cost of Revenue was $10.9 billion for Q1 2026 at Cvs Health, down from $59.1 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $175.1 billion in Q4 2024 and bottomed at -$47.6 billion in Q4 2022.
• A 5-year average of $39.4 billion and a median of $31.3 billion in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2024 — Cost of Revenue jumped 677.61% — and 2026, when it plunged 78.57%.
• Cvs Health's Cost of Revenue stood at -$47.6 billion in 2022, then jumped by 147.34% to $22.5 billion in 2023, then soared by 677.61% to $175.1 billion in 2024, then tumbled by 66.27% to $59.1 billion in 2025, then tumbled by 81.47% to $10.9 billion in 2026.
• Business Quant data shows CVS's Cost of Revenue at $10.9 billion in Q1 2026, $59.1 billion in Q4 2025, and $57.0 billion in Q3 2025.